Clinical evidence on PET/CT for radiation therapy planning in prostate cancer. (Articolo in rivista)

Type

• Articolo in rivista (Classe)
• Prodotto della ricerca (Classe)

Label

• Clinical evidence on PET/CT for radiation therapy planning in prostate cancer. (Articolo in rivista) (literal)

Anno

• 2010-01-01T00:00:00+01:00 (literal)

Alternative label

• Picchio M. 1,2, Giovannini E. 1, Crivellaro C. 2, Gianolli L. 1, Muzio N.D. 2, Messa C. 2,4,5 (2010)
  Clinical evidence on PET/CT for radiation therapy planning in prostate cancer.
  in Radiotherapy and oncology
  (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori

• Picchio M. 1,2, Giovannini E. 1, Crivellaro C. 2, Gianolli L. 1, Muzio N.D. 2, Messa C. 2,4,5 (literal)

Pagina inizio

• 347 (literal)

Pagina fine

• 350 (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume

• 96 (literal)

Rivista

• Radiotherapy and oncology (Rivista)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#note

• Review. Corresponding author: M. Picchio (picchio.maria@hsr.it) IF 2010: 4.337 (literal)

Note

• ISI Web of Science (WOS) (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni

• 1. Nuclear Medicine, San Raffaele Scientific Institute, Milano. 2. Molecular Bioimaging Center, University of Milano-Bicocca, Milano. 3. Radiation Oncology, San Raffaele Scientific Institute, Milano. 4. IBFM, National Research Council, Milano. 5. Nuclear Medicine, San Gerardo Hospital, Monza. (literal)

Titolo

• Clinical evidence on PET/CT for radiation therapy planning in prostate cancer. (literal)

Abstract

• The present chapter is focused on the role of positron emission tomography/computed tomography (PET/CT) and [11C]-labelled Choline ([11C]Choline) for the management of prostate cancer patients for radiation therapy planning. Although still a matter of debate, PET/CT with [11C]Choline is not routinely recommended for selecting patients for prostate cancer primary radiation treatment. However, due to its high accuracy in detecting and localizing recurrences when a biochemical failure occurs, [11C]Choline PET/CT may play a role in the re-staging phase to distinguish patients with local versus distant relapse, thus influencing patient management (curative versus palliative therapy). Limited data are currently available on the role of [11C]Choline PET/CT in target volume selection and delineation. According to available literature, [11C]Choline PET/CT is not clinically recommendable to plan target volume both for primary prostate treatment and for local recurrence. Nevertheless, promising data suggested a potential role of [11C]Choline PET/CT as an image guide tool for the irradiation of prostate cancer relapse. (literal)

Prodotto di

• Institute of molecular bioimaging and physiology (IBFM) (Istituto)
• Imaging molecolare in oncologia (ME.P06.006.003) (Modulo)

Autore CNR

• MARIA CRISTINA MESSA (Unità di personale esterno)

Insieme di parole chiave

• Parole chiave di "Clinical evidence on PET/CT for radiation therapy planning in prostate cancer." (Insieme di parole chiave)

Incoming links:

Autore CNR di

• MARIA CRISTINA MESSA (Unità di personale esterno)

Prodotto

• Institute of molecular bioimaging and physiology (IBFM) (Istituto)
• Imaging molecolare in oncologia (ME.P06.006.003) (Modulo)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi

• Radiotherapy and oncology (Rivista)

Insieme di parole chiave di

• Parole chiave di "Clinical evidence on PET/CT for radiation therapy planning in prostate cancer." (Insieme di parole chiave)